It is time for the world to take COPD seriously: a statement from the GOLD board of directors David M.G. Halpin, Bartolome R. Celli, Gerard J. Criner, Peter Frith, M. Victorina López Varela, Sundeep Salvi, Claus F. Vogelmeier, Ronchang Chen, Kevin Mortimer, Maria Montes de Oca, Zaurbek Aisanov, Daniel Obaseki, Rebecca Decker, Alvar Agusti Eur Respir J, 54 (1) 1900914; 10.1183/13993003.00914-2019 | |
Methylation, smoking, and reduced lung function Stephanie J. London Eur Respir J, 54 (1) 1900920; 10.1183/13993003.00920-2019 | |
Chronic cough: ATP, afferent pathways and hypersensitivity Richard D. Turner, Surinder S. Birring Eur Respir J, 54 (1) 1900889; 10.1183/13993003.00889-2019 | |
Potential antibiotic resistant pathogens in community-acquired pneumonia: playing it safe is anything but Grant W. Waterer Eur Respir J, 54 (1) 1900870; 10.1183/13993003.00870-2019 | |
Epigenome-wide association study of lung function level and its change Medea Imboden, Matthias Wielscher, Faisal I. Rezwan, André F.S. Amaral, Emmanuel Schaffner, Ayoung Jeong, Anna Beckmeyer-Borowko, Sarah E. Harris, John M. Starr, Ian J. Deary, Claudia Flexeder, Melanie Waldenberger, Annette Peters, Holger Schulz, Su Chen, Shadia Khan Sunny, Wilfried J.J. Karmaus, Yu Jiang, Gertraud Erhart, Florian Kronenberg, Ryan Arathimos, Gemma C. Sharp, Alexander John Henderson, Yu Fu, Päivi Piirilä, Kirsi H. Pietiläinen, Miina Ollikainen, Asa Johansson, Ulf Gyllensten, Maaike de Vries, Diana A. van der Plaat, Kim de Jong, H. Marike Boezen, Ian P. Hall, Martin D. Tobin, Marjo-Riitta Jarvelin, John W. Holloway, Deborah Jarvis, Nicole M. Probst-Hensch Eur Respir J, 54 (1) 1900457; 10.1183/13993003.00457-2019 | |
The effect of gefapixant, a P2X3 antagonist, on cough reflex sensitivity: a randomised placebo-controlled study Alyn H. Morice, Michael M. Kitt, Anthony P. Ford, Andrew M. Tershakovec, Wen-Chi Wu, Kayleigh Brindle, Rachel Thompson, Susannah Thackray-Nocera, Caroline Wright Eur Respir J, 54 (1) 1900439; 10.1183/13993003.00439-2019 | |
Broad-spectrum antibiotic use and poor outcomes in community-onset pneumonia: a cohort study Brandon J. Webb, Jeff Sorensen, Al Jephson, Ian Mecham, Nathan C. Dean Eur Respir J, 54 (1) 1900057; 10.1183/13993003.00057-2019 | |
Development and validation of the Adolescent Asthma Self-Efficacy Questionnaire (AASEQ) Simone Holley, Rebecca Knibb, Sue Latter, Christina Liossi, Frances Mitchell, Ruth Radley, Graham Roberts Eur Respir J, 54 (1) 1801375; 10.1183/13993003.01375-2018 | |
Quantifying the magnitude of pharyngeal obstruction during sleep using airflow shape Dwayne L. Mann, Philip I. Terrill, Ali Azarbarzin, Sara Mariani, Angelo Franciosini, Alessandra Camassa, Thomas Georgeson, Melania Marques, Luigi Taranto-Montemurro, Ludovico Messineo, Susan Redline, Andrew Wellman, Scott A. Sands Eur Respir J, 54 (1) 1802262; 10.1183/13993003.02262-2018 | |
Dual mechanism of action of T2 inhibitor therapies in virally induced exacerbations of asthma: evidence for a beneficial counter-regulation John Efthimiou, Chris Poll, Peter J. Barnes Eur Respir J, 54 (1) 1802390; 10.1183/13993003.02390-2018 | |
Intestinal organoids to model cystic fibrosis Peter van Mourik, Jeffrey M. Beekman, Cornelis K. van der Ent Eur Respir J, 54 (1) 1802379; 10.1183/13993003.02379-2018 | |
Nontuberculous mycobacterial pulmonary disease and Aspergillus co-infection: Bonnie and Clyde? Kim Geurts, Sanne M.H. Zweijpfenning, Lian J. Pennings, Jodie A. Schildkraut, Martin J. Boeree, Cecile Magis-Escurra, Henrich van der Lee, Paul E. Verweij, Wouter Hoefsloot, Jakko van Ingen Eur Respir J, 54 (1) 1900117; 10.1183/13993003.00117-2019 | |
Clarifying the diagnosis of post-inflammatory pulmonary fibrosis: a population-based study Ann Vu, Amit Vasireddy, Teng Moua, Misbah Baqir, Jay H. Ryu Eur Respir J, 54 (1) 1900103; 10.1183/13993003.00103-2019 | |
Lobectomy should remain the first choice for treating early stage nonsmall cell lung cancer Han-Yu Deng, Qinghua Zhou Eur Respir J, 54 (1) 1900649; 10.1183/13993003.00649-2019 | |
ERJ July Podcast: Nontuberculous mycobacteria
Eur Respir J, 54 (1) 19E5401; 10.1183/13993003.E5401-2019 | |
Treatment to prevent exacerbations in bronchiectasis: macrolides as first line? Irena F. Laska, James D. Chalmers Eur Respir J, 54 (1) 1901213; 10.1183/13993003.01213-2019 | |
Reducing childhood respiratory morbidity and mortality in low and middle income countries: a current challenge Cristina Ardura-Garcia, Claudia E. Kuehni Eur Respir J, 54 (1) 1900987; 10.1183/13993003.00987-2019 | |
Pulmonary Mycobacterium abscessus: can we identify the road to improved outcomes? David W. Connell, Morven Wilkie Eur Respir J, 54 (1) 1901121; 10.1183/13993003.01121-2019 | |
Same meat, different gravy: ignore the new names of mycobacteria Enrico Tortoli, Barbara A. Brown-Elliott, James D. Chalmers, Daniela M. Cirillo, Charles L. Daley, Stefan Emler, R. Andres Floto, Maria J. Garcia, Wouter Hoefsloot, Won-Jung Koh, Christoph Lange, Michael Loebinger, Florian P. Maurer, Kozo Morimoto, Stefan Niemann, Elvira Richter, Christine Y. Turenne, Ravikiran Vasireddy, Sruthi Vasireddy, Dirk Wagner, Richard J. Wallace, Nancy Wengenack, Jakko van Ingen Eur Respir J, 54 (1) 1900795; 10.1183/13993003.00795-2019 | |
Improving outcomes in patients with non-tuberculous mycobacterial disease: is there light at the end of the tunnel? Keertan Dheda Eur Respir J, 54 (1) 1901149; 10.1183/13993003.01149-2019 | |
No need for pulmonologists to interpret pulmonary function tests Christophe Delclaux Eur Respir J, 54 (1) 1900829; 10.1183/13993003.00829-2019 | |
Comparative risks of chronic inhaled corticosteroids and macrolides for bronchiectasis Emily Henkle, Jeffrey R. Curtis, Lang Chen, Benjamin Chan, Timothy R. Aksamit, Charles L. Daley, David E. Griffith, Kevin L. Winthrop Eur Respir J, 54 (1) 1801896; 10.1183/13993003.01896-2018 | |
An atypical pulmonary fibrosis is associated with co-inheritance of mutations in the calcium binding protein genes S100A3 and S100A13 Eid A. Al-Mutairy, Faiga Ahmad Imtiaz, Mohammed Khalid, Somaya Al Qattan, Soad Saleh, Linah Mahmood Mahmoud, Maher Mohammed Al-Saif, Latifa Al-Haj, Azizah Al-Enazi, Abdullah M. AlJebreen, Shamayel Faheem Mohammed, Abdullah Fahad Mobeireek, Khalid Alkattan, Muzamil Amin Chisti, Irina G. Luzina, Mohammed Al-Owain, Ihab Weheba, Abeer Mohamed Abdelsayed, Khushnooda Ramzan, Luke J. Janssen, Walter Conca, Ayodele Alaiya, Kate S. Collison, Brian F. Meyer, Sergei P. Atamas, Khalid S. Khabar, Jeffrey D. Hasday, Futwan Al-Mohanna Eur Respir J, 54 (1) 1802041; 10.1183/13993003.02041-2018 | |
IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis Malcolm R. Starkey, Maximilian W. Plank, Paolo Casolari, Alberto Papi, Stelios Pavlidis, Yike Guo, Guy J.M. Cameron, Tatt Jhong Haw, Anthony Tam, Ma'en Obiedat, Chantal Donovan, Nicole G. Hansbro, Duc H. Nguyen, Prema Mono Nair, Richard Y. Kim, Jay C. Horvat, Gerard E. Kaiko, Scott K. Durum, Peter A. Wark, Don D. Sin, Gaetano Caramori, Ian M. Adcock, Paul S. Foster, Philip M. Hansbro Eur Respir J, 54 (1) 1800174; 10.1183/13993003.00174-2018 | |
CCSP counterbalances airway epithelial-driven neutrophilic chemotaxis Lucie Knabe, Aurélie Petit, Charlotte Vernisse, Jérémy Charriot, Martine Pugnière, Corinne Henriquet, Souphatta Sasorith, Nicolas Molinari, Pascal Chanez, Jean-Philippe Berthet, Carey Suehs, Isabelle Vachier, Engi Ahmed, Arnaud Bourdin Eur Respir J, 54 (1) 1802408; 10.1183/13993003.02408-2018 | |
The occupations at increased risk of COPD: analysis of lifetime job-histories in the population-based UK Biobank Cohort Sara De Matteis, Deborah Jarvis, Andrew Darnton, Sally Hutchings, Steven Sadhra, David Fishwick, Lesley Rushton, Paul Cullinan Eur Respir J, 54 (1) 1900186; 10.1183/13993003.00186-2019 | |
The cumulative effect of inflammation and infection on structural lung disease in early cystic fibrosis Tim Rosenow, L. Clara Mok, Lidija Turkovic, Luke J. Berry, Peter D. Sly, Sarath Ranganathan, Harm A.W.M. Tiddens, Stephen M. Stick Eur Respir J, 54 (1) 1801771; 10.1183/13993003.01771-2018 | |
Characterisation of children hospitalised with pneumonia in central Vietnam: a prospective study Phuong T.K. Nguyen, Hoang T. Tran, Dominic A. Fitzgerald, Thach S. Tran, Stephen M. Graham, Ben J. Marais Eur Respir J, 54 (1) 1802256; 10.1183/13993003.02256-2018 | |
Analysis of loss to follow-up in 4099 multidrug-resistant pulmonary tuberculosis patients Ian F. Walker, Oumin Shi, Joseph P. Hicks, Helen Elsey, Xiaolin Wei, Dick Menzies, Zhiyi Lan, Dennis Falzon, Giovanni Battista Migliori, Carlos Pérez-Guzmán, Mario H. Vargas, Lourdes García-García, José Sifuentes Osornio, Alfredo Ponce-De-León, Martie van der Walt, James N. Newell Eur Respir J, 54 (1) 1800353; 10.1183/13993003.00353-2018 | |
Mycobacterium abscessus pulmonary disease: individual patient data meta-analysis Nakwon Kwak, Margareth Pretti Dalcolmo, Charles L. Daley, Geoffrey Eather, Regina Gayoso, Naoki Hasegawa, Byung Woo Jhun, Won-Jung Koh, Ho Namkoong, Jimyung Park, Rachel Thomson, Jakko van Ingen, Sanne M.H. Zweijpfenning, Jae-Joon Yim Eur Respir J, 54 (1) 1801991; 10.1183/13993003.01991-2018 | |
Non-tuberculous mycobacterial pulmonary disease Steven Cowman, Jakko van Ingen, David E. Griffith, Michael R. Loebinger Eur Respir J, 54 (1) 1900250; 10.1183/13993003.00250-2019 | |
Asthma progression and mortality: the role of inhaled corticosteroids Paul O'Byrne, Leonardo M. Fabbri, Ian D. Pavord, Alberto Papi, Stefano Petruzzelli, Peter Lange Eur Respir J, 54 (1) 1900491; 10.1183/13993003.00491-2019 | |
Geographic distribution of COPD prevalence in the world displayed by Geographic Information System maps Ignacio Blanco, Isidro Diego, Patricia Bueno, Francisco Casas-Maldonado, Marc Miravitlles Eur Respir J, 54 (1) 1900610; 10.1183/13993003.00610-2019 | |
Differential lung tissue gene expression in males and females: implications for the susceptibility to develop COPD Maarten van den Berge, Corry-Anke Brandsma, Alen Faiz, Maaike de Vries, Senani N.H. Rathnayake, Peter D. Paré, Don D. Sin, Yohan Bossé, Michel Laviolette, David C. Nickle, Ke Hao, Ma'en Obeidat, Tommaso A. Dragani, Francesca Colombo, Wim Timens, Dirkje S. Postma Eur Respir J, 54 (1) 1702567; 10.1183/13993003.02567-2017 | |
Similar characteristics of nontuberculous mycobacterial pulmonary disease in men and women Michael R. Holt, Shannon H. Kasperbauer, Tilman L. Koelsch, Charles L. Daley Eur Respir J, 54 (1) 1900252; 10.1183/13993003.00252-2019 | |
Failure with acquired resistance of an optimised bedaquiline-based treatment regimen for pulmonary Mycobacterium avium complex disease Sanne M.H. Zweijpfenning, Jodie A. Schildkraut, Jordy P.M. Coolen, Carolien Ruesen, Ellen Koenraad, Anne Janssen, Mike M. Ruth, Arjan S. de Jong, Saskia Kuipers, Rob E. Aarnoutse, Cecile Magis-Escurra, Wouter Hoefsloot, Jakko van Ingen Eur Respir J, 54 (1) 1900118; 10.1183/13993003.00118-2019 | |
Outcomes of hypertonic saline inhalation as a treatment modality in nontuberculous mycobacterial pulmonary disease Anne Huiberts, Sanne M.H. Zweijpfenning, Lian J. Pennings, Martin J. Boeree, Jakko van Ingen, Cecile Magis-Escurra, Wouter Hoefsloot Eur Respir J, 54 (1) 1802143; 10.1183/13993003.02143-2018 | |
Inhaled corticosteroids attenuate epithelial mesenchymal transition: implications for COPD and lung cancer prophylaxis Wenying Lu, Pawan Sharma, Mathew Suji Eapen, Sukhwinder Singh Sohal Eur Respir J, 54 (1) 1900778; 10.1183/13993003.00778-2019 | |
Demystifying fibrotic hypersensitivity pneumonitis diagnosis: it's all about shades of grey Simon L.F. Walsh, Luca Richeldi Eur Respir J, 54 (1) 1900906; 10.1183/13993003.00906-2019 | |
Detrimental effects of air pollution on adult lung function Edith B. Milanzi, Ulrike Gehring Eur Respir J, 54 (1) 1901122; 10.1183/13993003.01122-2019 | |
Decrease in blood pressure during continuous positive airway pressure treatment for obstructive sleep apnoea: still searching for predictive factors Oreste Marrone, Maria R. Bonsignore Eur Respir J, 54 (1) 1901219; 10.1183/13993003.01219-2019 | |
Diagnosis and outcome of acute respiratory failure in immunocompromised patients after bronchoscopy Philippe R. Bauer, Sylvie Chevret, Hemang Yadav, Sangeeta Mehta, Peter Pickkers, Ramin B. Bukan, Jordi Rello, Andry van de Louw, Kada Klouche, Anne-Pascale Meert, Ignacio Martin-Loeches, Brian Marsh, Lorenzo Socias Crespi, Gabriel Moreno-Gonzalez, Nina Buchtele, Karin Amrein, Martin Balik, Massimo Antonelli, Martine Nyunga, Andreas Barratt-Due, Dennis C.J.J. Bergmans, Angélique M.E. Spoelstra-de Man, Anne Kuitunen, Florent Wallet, Amelie Seguin, Victoria Metaxa, Virginie Lemiale, Gaston Burghi, Alexandre Demoule, Thomas Karvunidis, Antonella Cotoia, Pål Klepstad, Ann M. Møller, Djamel Mokart, Elie Azoulay Eur Respir J, 54 (1) 1802442; 10.1183/13993003.02442-2018 | |
Variable utility of mosaic attenuation to distinguish fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis Joseph Barnett, Philip L. Molyneaux, Bhavin Rawal, Rezaur Abdullah, Samanjit S. Hare, Rama Vancheeswaran, Sujal R. Desai, Toby M. Maher, Athol U. Wells, Anand Devaraj Eur Respir J, 54 (1) 1900531; 10.1183/13993003.00531-2019 | |
Air pollution, lung function and COPD: results from the population-based UK Biobank study Dany Doiron, Kees de Hoogh, Nicole Probst-Hensch, Isabel Fortier, Yutong Cai, Sara De Matteis, Anna L. Hansell Eur Respir J, 54 (1) 1802140; 10.1183/13993003.02140-2018 | |
Differential blood pressure response to continuous positive airway pressure treatment according to the circadian pattern in hypertensive patients with obstructive sleep apnoea Esther Sapiña-Beltrán, Gerard Torres, Iván Benítez, Fernando Santamaría-Martos, Joaquín Durán-Cantolla, Carlos Egea, Manuel Sánchez-de-la-Torre, Ferrán Barbé, Mireia Dalmases Eur Respir J, 54 (1) 1900098; 10.1183/13993003.00098-2019 | |
Mean nocturnal respiratory rate predicts cardiovascular and all-cause mortality in community-dwelling older men and women Mathias Baumert, Dominik Linz, Katie Stone, R. Doug McEvoy, Steve Cummings, Susan Redline, Reena Mehra, Sarah Immanuel Eur Respir J, 54 (1) 1802175; 10.1183/13993003.02175-2018 | |
Changing trends in age-adjusted pulmonary fibrosis mortality in the USA: a joinpoint regression analysis Evans R. Fernández Pérez Eur Respir J, 54 (1) 1900364; 10.1183/13993003.00364-2019 | |
Early access to bedaquiline for extensively drug-resistant (XDR) and pre-XDR tuberculosis Irina Vasilyeva, Andrei Mariandyshev, Boris Kazennyy, Edita Davidaviciene, Nacer Lounis, Sofia Keim Eur Respir J, 54 (1) 1802208; 10.1183/13993003.02208-2018 | |
“Do bacteria have a role in asthma development?” J. Armann and E. von Mutius. Eur Respir J 2010; 36: 469–471.
Eur Respir J, 54 (1) 1050414; 10.1183/13993003.50414-2010 | |